Trevisan & Cuonzo

Life Sciences Department

Current View:

This content is provided by Trevisan & Cuonzo.


Life Sciences

Trevisan & Cuonzo has acquired a reputation of excellence for its top quality expertise in the complex issues raised by contentious pharmaceutical and biotech litigation.  As a regular and player before the Italian IP Courts, and with solid experience working with other European law firms in defending the Italian arm of pan-European pharma litigation, the firm is in a formidable position to serve both Italian and international clients in this sector.

On the transactional front clients range from bio-tech start-ups to medium and very well established pharma businesses with Blockbuster products on the Italian market. Advice and strategy are sought on capital formation guidance for start-ups, licensing agreements for technology transfer, distribution, manufacture and supply agreements, joint venture research and development collaboration agreements, clinical trial and clinical research agreements as well as high profile partnering deals.

The firm is regularly advise on Italian and European anti-competitive issues in the pharmaceutical sector as well as handling regulatory matters such as data exclusivity, Italian market authorisation and matters relating to patent extensions. 

Significant clients AGA Medical Group, Boehringer Ingelheim,  Angiotech, AstraZeneca, Novartis, Amgen